Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression

BackgroundZFAS1 is a newly identified long noncoding RNA (lncRNA) that promotes tumor growth and metastasis. Exosomes mediate cellular communications in cancer by transmitting active molecules. The presence of ZFAS1 in the circulating exosomes and the roles of exosomal ZFAS1 in gastric cancer (GC) remains unknown. The aim of this study was to investigate the potential roles of exosomal ZFAS1 in GC.MethodsThe expression of ZFAS1 was examined in the tumor tissues, serum samples, serum exosomes of GC patients and cell lines using qRT-PCR. The correlation between ZFAS1 expression and the clinicopathological characteristics was analyzed. The characteristics of exosomes were identified using transmission electron microscope (TEM), Nanoparticle Tracking Analysis (NTA), and western blot. The biological roles of ZFAS1 in GC cell growth and mobility were investigated using cell counting, cell colony formation, and transwell migration assay. The potential mechanism of ZFAS1 was demonstrated using flow cytometry, western blot, and qRT-PCR.ResultsZFAS1 expression was elevated in GC cells, tumor tissues, serum and serum exosomes of GC patients. The increased ZFAS1 expression was significantly correlated with lymphatic metastasis and TNM stage. ZFAS1 knockdown inhibited the proliferation and migration of GC cells by suppressing cell cycle progression, inducing apoptosis, and inhibiting epithelial-mesenchymal transition (EMT). On the contrary, ZFAS1 overexpression promoted the proliferation and migration of GC cells. Moreover, ZFAS1 was present in exosomes and could be transmitted by exosomes to enhance GC cell proliferation and migration.ConclusionZFAS1 could be delivered by exosomes to promote GC progression, which suggests that ZFAS1 may serve as a potential diagnostic and prognostic biomarker for GC.

[1]  P. Ma,et al.  Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  C. Xing,et al.  Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer. , 2016, Pathology, research and practice.

[3]  Lijun Wu,et al.  Exosomes in cancer: small particle, big player , 2015, Journal of Hematology & Oncology.

[4]  Z. Pan,et al.  Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression , 2016, Tumor Biology.

[5]  Su-jin Yang,et al.  Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222 , 2016, Tumor Biology.

[6]  Hao Chen,et al.  Increased expression of long-noncoding RNA ZFAS1 is associated with epithelial-mesenchymal transition of gastric cancer , 2016, Aging.

[7]  J. Mattick,et al.  SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. , 2011, RNA.

[8]  Y. Shao,et al.  LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer , 2016, Oncotarget.

[9]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.

[10]  Y. Shao,et al.  Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance , 2015, Tumor Biology.

[11]  Yanjie Lu,et al.  Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction , 2016, Scientific Reports.

[12]  Ming Sun,et al.  Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression , 2016, Oncotarget.

[13]  Chuan Shen,et al.  Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma. , 2015, Cancer research.

[14]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[15]  Yuchen Liu,et al.  Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer , 2016, Journal of Experimental & Clinical Cancer Research.

[16]  Bo Li,et al.  The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway , 2016, Journal of Cancer Research and Clinical Oncology.

[17]  Su-jin Yang,et al.  MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes , 2016, Oncotarget.

[18]  U. Gezer,et al.  Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease , 2015, Front. Genet..

[19]  D. Weaver,et al.  Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology , 2015, Journal of Clinical Pathology.

[20]  Hailong Fu,et al.  Exosomal non-coding RNAs: a promising cancer biomarker , 2016, Clinical chemistry and laboratory medicine.

[21]  B. Xiao,et al.  Molecular mechanisms of long noncoding RNAs on gastric cancer , 2016, Oncotarget.

[22]  P. Gao,et al.  A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion , 2016, Journal of Cancer Research and Clinical Oncology.

[23]  Jin Ding,et al.  Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. , 2016, Cancer cell.

[24]  Lei Dong,et al.  Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[25]  J. Roa,et al.  Long non-coding RNAs in gastric cancer: mechanisms and potential applications , 2015 .

[26]  R. Hong,et al.  Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma , 2016, Oncology letters.

[27]  Y. Shao,et al.  Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer , 2015, Tumor Biology.

[28]  Shuhan Sun,et al.  Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma , 2015, Journal of Cancer Research and Clinical Oncology.

[29]  Rosalind J Wright,et al.  Detection of long non-coding RNAs in human breastmilk extracellular vesicles: Implications for early child development , 2016, Epigenetics.

[30]  Hongjiang Liu,et al.  Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. , 2015, International journal of clinical and experimental pathology.

[31]  Michele Ceccarelli,et al.  Detection of long non–coding RNA homology, a comparative study on alignment and alignment–free metrics , 2018, BMC Bioinformatics.

[32]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[33]  M. Kretz,et al.  Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer , 2015, OncoTarget.

[34]  Hongjiang Liu,et al.  Original Article Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition , 2015 .

[35]  Y. Sang,et al.  LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression , 2016, Scientific Reports.